Cargando…

Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months

Detalles Bibliográficos
Autores principales:	Peng, Pai, Hu, Jie, Deng, Hai-jun, Liu, Bei-zhong, Fang, Liang, Wang, Kai, Tang, Ni, Huang, Ai-long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791534/ https://www.ncbi.nlm.nih.gov/pubmed/33420358 http://dx.doi.org/10.1038/s41423-020-00605-4

Ejemplares similares

Correction: Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months
por: Peng, Pai, et al.
Publicado: (2022)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine
por: Peng, Pai, et al.
Publicado: (2021)

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
por: Barouch, Dan H., et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021)

Sustainability of SARS-CoV-2 Induced Humoral Immune Responses in COVID-19 Patients from Hospitalization to Convalescence Over Six Months
por: Zheng, Yang, et al.
Publicado: (2021)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
por: Uriu, Keiya, et al.
Publicado: (2021)

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
por: Anand, Sai Priya, et al.
Publicado: (2021)

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
por: Ni, Ling, et al.
Publicado: (2020)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

The fragility of humoral immunity as a physiological safety marker for healthcare workers to return after COVID-19 convalescence
por: Silva, Vânia Lúcia, et al.
Publicado: (2021)

Protective humoral immunity in SARS-CoV-2 infected pediatric patients
por: Zhang, Yaguang, et al.
Publicado: (2020)

SARS-CoV-2 RNA Detection in Gastrointestinal Sample Displays Poor Performance
por: Xing, Xiao-Cun, et al.
Publicado: (2021)

Convalescents
Publicado: (1907)

Maintenance of neutralizing antibodies over ten months in convalescent SARS‐CoV‐2 afflicted patients
por: Sonnleitner, Sissy Therese, et al.
Publicado: (2021)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

Bronchial Mucosal Microcirculation in SARS-CoV-2 Infection: Role in Innate Humoral Defense?
por: Persson, Carl
Publicado: (2022)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
por: Miyakawa, Kei, et al.
Publicado: (2021)

Humoral Response in SARS-CoV-2 Convalescent Compared to Vaccinated Kidney Transplant Patients
por: Schimpf, Judith, et al.
Publicado: (2022)

Stability of hybrid versus vaccine immunity against BA.5 infection over 8 months
por: Malato, João, et al.
Publicado: (2023)

Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection
por: Wang, Hao, et al.
Publicado: (2021)

Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
por: Jian, Fanchong, et al.
Publicado: (2022)

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
por: Zabalza, Ana, et al.
Publicado: (2022)

SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV()
por: Giannone, Denise, et al.
Publicado: (2022)

Dichotomy between the humoral and cellular responses elicited by mRNA and adenoviral vector vaccines against SARS-CoV-2
por: Ukey, Rahul, et al.
Publicado: (2022)

Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
por: Harrington, Patrick, et al.
Publicado: (2022)

Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
por: Alcheikh, Ahmad, et al.
Publicado: (2023)

Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains
por: Pan, Ting, et al.
Publicado: (2021)

Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients
por: Khan, Qamar J., et al.
Publicado: (2022)

SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
por: Wu, Jun, et al.
Publicado: (2021)

SARS-CoV-2, diabetes and mortality: month by month variation in mortality rate from June 2020 to June 2021
por: Heald, Adrian H., et al.
Publicado: (2022)

Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine
por: Prendecki, Maria, et al.
Publicado: (2021)

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
por: Butler, Savannah E., et al.
Publicado: (2021)

Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies
por: Maglione, Alessandro, et al.
Publicado: (2022)

A three-dose inactivated SARS-CoV-2 vaccine is sufficient to elicit humoral immune responses in people living with HIV-1
por: Yu, Haisheng, et al.
Publicado: (2023)

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Use of convalescent plasma in the treatment of COVID-19
por: Joyner, Michael J., et al.
Publicado: (2023)

Late Treatment for COVID-19 With Convalescent Plasma
por: Senefeld, Jonathon W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t6l8cvu5btiso23d92s1j5v253